Association of xeroderma pigmentosum with thrombasthenia

Turkish Journal of Pediatrics

Volumn 38, Issue 2, 1996, Pages 261-264

  Hasanoǧlu, Alev ^a   Gücüyener, Kivilcim ^a   Tümer, Leyla ^a   Gürsel, Türkiz ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Glanzmann's thrombosthenia; xeroderma pigmentosum

Indexed keywords

ISOTRETINOIN;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; DNA REPAIR; ERYTHEMA; FEMALE; GLANZMANN DISEASE; HUMAN; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; SCHOOL CHILD; SKIN CANCER; THROMBOCYTE AGGREGATION; XERODERMA PIGMENTOSUM;

CHILD; FEMALE; HUMANS; SKIN NEOPLASMS; THROMBASTHENIA; XERODERMA PIGMENTOSUM;

EID: 0029901493     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bohr AV, Evans KV. Heterogeneity of DNA repair: implications for human disease and oncology. Pediatr Hem Oncol 1990; 7: 47-69.
2. English JS, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117: 457-461.
3. Stuart MJ, Kelton JG. The platelet: quantitative and qualitative abnormalities. In: Nathan D, Oski F (eds). Hematology of Infancy and Childhood, Volume II. London: Saunders Co; 1987: 1436-1437.
4. Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260: 384-388.
5. Robbins JH, Kraemer KH, Lutaner MA. An inherited disease with sun sensitivity, multiple cutaneous neoplasms and abnomal DNA repair. Ann Intern Med 1974; 80: 221-226.
6. Wood DR, Robins P, Lindhal T. Complementation of the xeroderma pigmentosum DNA repair defect in cell free extracts. Cell 1988; 53: 97-106.
7. Kenyon GS, Booth BJ, Prasher DK, Rudge P. Neuro-otological abnormalities in xeroderma pigmentosum with particular reference to deafness. Brain 1985; 108: 771-784.
8. Mimaki T, Itoh N, Abe J, et al. Neurological manifestations in xeroderma pigmentosum. Ann Neurol 1986; 20: 70-75.
9. Mimaki T, Tagowa T, Tanaka J, Sato K, Yabuuchi H. EEG and CT abnormalities in xeroderma pigmentosum. Acta Neurol Scand 1989; 80: 136-141.
10. Hiçsönmez G. Congenital qualitative platelet disorders in children. Report on 60 patients. Turk J Pediatr 1982; 24: 21-28.
11. Osguthorpe JD, Lang P. Management of xeroderma pigmentosum. Arch Otolaryngol Head Neck Surg 1987; 113: 292- 294.
12. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633-1637.
13. Bithell TC. Qualitative disorders of platelet function. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds). Wintrobe's Clinical Hematology, Volume II. London: Lea and Febiger; 1993: 1397-1422.
14. Nuzzo F, Zei G, Stefanini M, et al. Search for consanguinity within and among families of patients with trichothiodystrophy associated with xeroderma pigmentosum. J Med Genet 1990; 27: 21-25.